10.1139/cjpp-2012-0118 38 FischerA.OnurS.NiklowitzP.MenkeT.LaudesM.RimbachG.et al
Safety Profile and Considerations for BPC-157 in Joint Applications BPC-157 appears remarkably safe in both animal models[7] and early human observations, but definitive large-scale clinical trials are still lacking
While we will ask for your preference, our recommended dose will always be data-backed
All products are supplied exclusively under the RUO exemption in FDA Guidance "Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only" (2013) and 21 C.F.R
In addition, a small pilot safety study published in Alternative Therapies in Health and Medicine showed that intravenous infusions of BPC-157 up to 20 milligrams were well-tolerated with no reported adverse effects in healthy adults, providing initial evidence that the peptide can be administered safely, a necessary step before larger efficacy trials on healing outcomes are conducted
Osuga Y, Harada K, Tsuboi T
